Zhen Ren
FDA investigator
Appears on 1 document from 2024, mostly at sites in Pennsylvania. Most often cites written procedures; deviations (21 CFR 211.100).
- 1
- Documents on file
- 5.0
- Observations per 483
- 2024
- First seen
- 2024
- Most recent
What they cite most
From 5 observations- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.192Production record review1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.42Design and construction features1
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures1
Activity by year
2024: 1
Where
Pennsylvania 1
Often inspects with
Is Zhen Ren coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2024-09-25 | 483 GlaxoSmithKline LLCSep 25, 2024 · Conshohocken, Pennsylvania | Conshohocken, Pennsylvania | 5 |
About this profile
What does Zhen Ren inspect?
Zhen Ren appears on 1 document on file covering 1 site, mostly in Pennsylvania.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.192 and 21 CFR 211.22.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Zhen Ren is dated Sep 25, 2024.